Markeri ultrasonografici intracranieni în spina bifida aperta
Intracranial ultrasonographic findings in open spina bifida
Abstract
Spina bifida aperta is one of the most frequent open neural tube defects and consists in a closure defect in the fetal spine and the subsequent skin, leaving the spinal cord vulnerable. Since folic acid supplementation has been recommended periconceptionally, the incidence of neural tube defects, including spina bifida, has been reduced dramatically. Unfortunately, spina bifida is usually diagnosed in the second trimester, more frequently between 18 and 20 weeks of gestation, according to the American College of Obstetricians and Gynecologists (ACOG), by visualizing the spinal defect, as well as well-known intracranial signs. There have been attempts in finding the right intracranial sign or measurement that can predict a future positive diagnosis of spina bifida or at least alert the sonographer to further investigate. The early diagnosis of spina bifida represents the subject of interest of this paper, as this congenital neural tube defect carries the burden of a significant morbidity. The mothers should be counseled, informed about the fetal complications of this pathology and about the therapeutic possibilities, including intrauterine fetal surgery, and they should also be given the possibility of pregnancy termination, if the patient decides in this direction.
Keywords
spina bifidaearly signsintracranial translucencybrain stemmesencephalon to occiput diameterRezumat
Spina bifida aperta este una dintre cele mai frecvente defecte de tub neural și constă într-un defect de închidere la nivelul coloanei vertebrale fetale și, respectiv, a pielii, lăsând măduva spinării vulnerabilă. Datorită faptului că suplimentarea cu acid folic a fost recomandată periconcepțional, incidența defectelor de tub neural (inclusiv spina bifida) a fost redusă dramatic. Din păcate, spina bifida este adesea diagnosticată doar în al doilea trimestru, mai frecvent între 18 și 20 de săptămâni de gestație, conform Colegiului American al Obstetricienilor și Ginecologilor (ACOG), prin vizualizarea defectului coloanei vertebrale, precum și a semnelor intracraniene bine cunoscute. Numeroase eforturi au fost îndreptate spre a găsi markerul intracranian corect și predictiv pentru spina bifida, capabil de a avertiza ecografistul asupra existenței, vizibile sau nu la momentul scanării, a unui defect de tub neural. Diagnosticul precoce al spina bifida reprezintă subiectul de interes al articolului, deoarece acest defect congenital poartă povara unei morbidități semnificative. Gravida trebuie consiliată cu privire la complicațiile fetale ale acestei patologii și în privinţa posibilităților terapeutice, incluzând indicațiile și disponibilitatea intervenției chirurgicale intrauterine fetale. De asemenea, diagnosticul în trimestrul întâi de sarcină permite luarea în considerare a întreruperii sarcinii, la cererea pacientei, în condiții legale.
Cuvinte Cheie
spina bifidasemne precocetranslucență intracranianătrunchi cerebraldiametrul mezencefal-occiputIntroduction
Open spina bifida – known as spina bifida aperta or myelomeningocele – represents the most common open neural tube defect, characterized by a breach in the vertebral column with a subsequent defect in the skin through which the spinal cord is exposed(1). This neural tube defect appears as a result of the closing failure of the embryonic neural tube by the 28th day after conception(2). The incidence of neural tube defects – with spina bifida aperta being the most frequent in this category – has a variability between (3-5).
The main risk factors for the majority of neural tube defects are represented by folate deficiency(7), genetic factors(8), syndromes that can be associated with neural tube defects, fever or even hyperthermia, obesity(9), and pregestational diabetes(10). Folate deficiency can be either due to insufficient oral intake(7), defective intestinal absorption, genetic factors interfering with the normal folate metabolism or to the administration of folic acid antagonists (carbamazepine, valproic acid or methotrexate)(7,11). Since folic acid supplementation has been introduced periconceptionally, the incidence of neural tube diseases has decreased significantly(12).
The most common screening test for myelomeningocele is represented by ultrasound examination (Figures 1 and 2). The American College of Obstetricians and Gynecologists (ACOG) recommends that a high-quality second trimester structural fetal screening test at 18 to 20 weeks of gestation should include screening for neural tube defects, including spina bifida(13), as this congenital anomaly is associated with certain degrees of neurological impairment and with a possible cognitive function impairment if ventriculomegaly or a genetic syndrome is involved. Besides the spinal lesion, the brain suffers certain changes, establishing the Chiari II malformation: a small posterior fossa with a herniation of the cerebellum and the vermian structures through the tentorial incisura and the foramen magna, resulting in an abnormal cerebellar morphology and a deformation of the brainstem structures, pons, medulla and fourth ventricle(14,15). Although second-trimester ultrasonographic screening allows a good fetal anatomy examination and spina bifida diagnosis, there have been studies trying to evaluate fetuses within the first-trimester anatomy scan, but the detection rates remain lower (44%) than those in the second trimester (92% to 95%)(16).
The early diagnosis should be considered, as mothers must be informed, counseled about further investigations such as chromosomal microarray or gene sequencing, as well as fetal magnetic resonance imagining, prepared to give birth to an infant with multiple complications, probably necessitating surgery, or be given the possibility of pregnancy termination if desired.
Second-trimester ultrasonographic intracranial signs in spina bifida
A systematic review published in 2021 by Kunpalin et al.(15), including 15 studies, summarized the intracranial sonographic findings present in myelomeningocele: funneling of the posterior fossa, banana sign (abnormal shape and anteriorly effacing cerebellum) – Figure 3, lemon sign (inward concavity interesting the frontal bones), small transcerebellar diameter, abnormal shape of the midbrain, small biparietal diameter, perinodular heterotopia, small head circumference, gyration disorders, abnormal corpus callosum, ventriculomegaly, abnormal position or shape of the lateral ventricle and interhemispheric arachnoid cyst. In addition, there were nine studies relating modifications belonging to Chiari II malformation: scalloping of the frontal bones of the fetal head, abnormalities of the cerebellum, abnormal shape of the posterior fossa and elongated quadrigeminal plate of the midbrain, that may cause cognitive and attention deficits, stridor, poor executive skills and apnea(17).
First-trimester ultrasonographic intracranial signs in spina bifida
As a need to diagnose this neural tube defect with significant morbidity, certain first-trimester ultrasonographic signs that might help in the early diagnosis of spina bifida have been described during the first-trimester fetal anatomy screening. The pioneers in this direction were Chaoui and Nicolaides(18) in 2009, suggesting the use of a intracranial measurement called intracranial translucency (IT) – Figure 4, which is actually the fourth ventricle in the mid sagittal view, used for detecting nuchal translucency (NT). Due to caudal displacement of the brain, the fourth ventricle is compressed and no longer visible in the cases that were subsequently diagnosed during the second trimester presenting the “banana” and “lemon” signs.
A year later, a study(19) regarding the first-trimester fetal anatomy ultrasonographic examination, which compared measurements of brain stem (BS) diameter, brain stem to occipital bone (BSOB) diameter and brain stem to BSOB ratio from images of 30 cases of open spina bifida with a control group involving images from 1000 cases of normal fetuses, has sustained that in cases of spina bifida aperta, BS and the BS to BSOB ratio are high and the BSOB diameter is lower compared to normal fetuses (Figure 5). Such intracranial findings should warn the sonographer to examine more carefully the spine, and in cases of imperfect images, the examination should be delayed for two or three weeks.
In 2011, a study by Finn et al.(20) revealed that the included cases of neural tube defects presented a diameter between the aqueduct of Sylvius and the occiput below the normal range in accordance to the crown-rump length and gestational age, which, although not considered a diagnostic ultrasonographic marker, it helps the sonographer and afterwards lead to a positive diagnosis of spina bifida (Figure 6).
Another interesting intracranial measurement described by Nemescu et al.(21) in an article published in 2020 alerts sonographers about the possibility of early diagnosing spina bifida. The authors reveal the results of measurement between the mesencephalon and occiput in the axial view of the head (Figure 6), which is increased in women who have not received folic acid supplementation and could – in association with the “crash sign” (the deformed and posteriorly displaced mesencephalon against the occipital bone)(22) – aid in selecting the cases that require detailed neural tube defects examination and improve prompt diagnosis of spina bifida.
Discussion
Positive diagnosis of spina bifida is currently being made during the second-trimester anatomical ultrasound when a bulging defect that contains elevated neural plate and meninges juxtaposed laterally with the subcutaneous tissue. The normal vertebral column has three ossification centers within the vertebrae. Myelomeningocele presents as a widening of the ossification centers in the coronal plane and as a separation of the ossification centers in the transverse plane, resulting a U-shaped vertebra(23). The sensibility and specificity in prenatal ultrasonographic diagnosis of spina bifida are 97-98% and 100%, respectively(24). The diagnosis is sustained by the intracranial signs. The recent ultrasonographic measurements – intracranial translucency, brain stem, brain stem to occipital bone diameter, brain stem to BSOB ratio, aqueduct of Sylvius to the occiput diameter and mesencephalon to occiput diameter – in association with the “crash sing” have the potential of selecting the cases that require a detailed examination of the spine during the first-trimester ultrasonographic screening or in the next period, in order to refer pregnant patients with a high suspicion of spina bifida to supplementary investigations.
Conclusions
In conclusion, further studies are required to demonstrate the effectiveness of the highly promising first-trimester ultrasound measurements, either separate or combined, in order to select the high-risk cases of spina bifida. If the results validate the high sensibility and specificity, these measurements could be easily introduced in the first-trimester anatomical screening, as the ultrasound sections used for the measurements are the standard ones for determining the biparietal diameter or the nuchal translucency. Therefore, patients will be informed and counseled about the implications of this pathology with important morbidity and decide whether they will terminate the pregnancy or assume the surgical correction procedures that have to be done postnatal or even from intrauterine life in order to decrease the neurological damage due to the herniation of the cerebellum and the vermian structures through the tentorial incisura and the foramen magna.
Conflicts of interests: The authors declare no conflict of interests.
Bibliografie
- Sirico A, Raffone A, Lanzone A, Saccone G, Travaglino A, Sarno L, Rizzo G, Zullo F, Maruotti GM. First trimester detection of fetal open spina bifida using BS/BSOB ratio. Arch Gynecol Obstet. 2020;301(2):333-40.
- Copp AJ, Adzick NS, Chitty LS, Fletcher JM, Holmbeck GN, Shaw GM. Spina bifida. Nat Rev Dis Primers. 2015;30(1):15007.
- Canfield MA, Annegers JF, Brender JD, Cooper SP, Greenberg F. Hispanic origin and neural tube defects in Houston/Harris County, Texas, II Risk Factors. Am J Epidemiol. 1996;143(1):12-24.
- Khoshnood B, Loane M, de Walle H, Arriola L, Addor MC, Barisic I, Beres J, Bianchi F, Dias C, Draper E, Garne E, Gatt M, Haeusler M, Klungsoyr K, Latos-Bielenska A, Lynch C, McDonnell B, Nelen V, Neville AJ, O’Mahony MT, Queisser-Luft A, Rankin J, Rissmann A, Ritvanen A, Rounding C, Sipek A, Tucker D, Verellen-Dumoulin C, Wellesley D, Dolk H. Long term trends in prevalence of neural tube defects in Europe: population-based study. BMJ. 2015;351:h5949.
- Blencowe H, Kancherla V, Moorthie S, Darlison MW, Modell B. Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Ann NY Acad Sci. 2018;1414(1):31-46.
- Copp AJ, Stanier P, Greene ND. Neural tube defects: recent advances, unsolved questions, and controversies. Lancet Neurol. 2013;12(8):799-810.
- Wen SW, Walker M. Risk of fetal exposure to folic acid antagonists. J Obstet Gynaecol Can. 2004;26(5):475-80.
- Ross ME, Mason CE, Finnell RH. Genomic approaches to the assessment of human spina bifida risk. Birth Defects Res. 2017;109(2):120-8.
- Racusin D, Stevens B, Campbell G, Aagaard KM. Obesity and the risk and detection of fetal malformations. Semin Perinatol. 2012;36(3):213-21.
- Gabbay-Benziv R, Reece EA, Wang F, Yang P. Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis. World J Diabetes. 2015;6(3):481-8.
- Ornoy A. Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod Toxicol. 2006;22(2):214-26.
- Mills JL. Strategies for preventing folate-related neural tube defects: supplements, fortified foods, or both? JAMA. 217l;317(2):144-5.
- ACOG. Practice Bulletin No. 187: Neural tube defects. Obstet Gynecol. 2017;130(6):e279-e290.
- Sarnat HB. Disorders of segmentation of the neural tube: Chiari malformations. Handb Clin Neurol. 2008;87:89-103.
- Kunpalin Y, Richter J, Mufti N, Bosteels J, Ourselin S, De Coppi P, Thompson D, David AL, Deprest J. Cranial findings detected by second-trimester ultrasound in fetuses with myelomeningocele: a systematic review. BJOG. 2021;128(2):366-74.
- Cameron M, Moran P. Prenatal screening and diagnosis of neural tube defects. Prenat Diagn. 2009;29(4):402-11.
- Naidich TP, McLone DG, Fulling KH. The Chiari II malformation: Part IV. The hindbrain deformity. Neuroradiology. 1983;25(4):179-97.
- Chaoui R, Benoit B, Mitkowska-Wozniak H, Heling KS, Nicolaides KH. Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan. Ultrasound Obstet Gynecol. 2009;34(3):249-52.
- Lachmann R, Chaoui R, Moratalla J, Picciarelli G, Nicolaides KH. Posterior brain in fetuses with open spina bifida at 11 to 13 weeks. Prenat Diagn. 2011;31(1):103-6.
- Finn M, Sutton D, Atkinson S, Ransome K, Sujenthiran P, Ditcham V, Wakefield P, Meagher S. The aqueduct of Sylvius: a sonographic landmark for neural tube defects in the first trimester. Ultrasound Obstet Gynecol. 2011;38(6):640-5.
- Nemescu D, Adam AM, Tanasă IA, Socolov D, Bohîlţea RE, Navolan DB, Zvăncă ME. Reference ranges for the fetal mesencephalon to occiput measurement at 11 to 13+6 weeks of gestation. Exp Ther Med. 2020;20(3):2475-80.
- Ushakov F, Sacco A, Andreeva E, Tudorache S, Everett T, David AL, Pandya PP. Crash sign: new first-trimester sonographic marker of spina bifida. Ultrasound Obstet Gynecol. 2019;54(6):740-5.
- Blumenfeld Z, Siegler E, Bronshtein M. The early diagnosis of neural tube defects. Prenat Diagn. 1993;13(9):863-71.
- Lennon CA, Gray DL. Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population. Obstet Gynecol. 1999;94(4):562-6.